Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

First-line Treatment of Non-Small Cell Lung Cancer Under Routine Conditions: Observational Study on Overall Survival

NCT01067794 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.

NCT NCT01067794
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01067794 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
First-line Treatment of Non-Small Cell Lung Cancer Under Routine Conditions: Observational Study on Overall Survival
Lead sponsor
Eli Lilly and Company
Phase
Observational
Overall status
Completed
Start date
April 30, 2009
Completion date
July 31, 2012
Enrollment
1,610 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

non small cell lung cancer